不确定潜力的克隆性血液形成与发生的腹腔大动脉动脉瘤有关
Yu Tan1,2,3, Xuanmeng Zhu1,2,3, Yuanfeng Huang4,5
1Department of Cardiovascular Medicine, Xiangya Hospital, Central South University, Changsha, China. (Y.T., X.Z., C.Z., X.C., G.Z., T.M., S.Y.).
概括
不确定潜力的克隆性血液形成 (CHIP) 增加了腹腔大动脉瘤 (AAA) 的风险. 遗传性互白素-6 (IL-6) 缺乏可能会降低CHIP载体的AAA风险,这表明CHIP是潜在的治疗点.
科学领域:
- 心血管医学 心血管医学
- 遗传学 遗传学 是一个
- 血液学 血液学 血液学
背景情况:
- 不确定潜力的克隆性血液形成 (CHIP) 是一种新兴的心血管疾病风险因素.
- CHIP与腹腔大动脉瘤 (AAA) 风险之间的联系,以及IL-6信号在这种关联中的作用,仍然不清楚.
研究的目的:
- 调查CHIP和事件AAA之间的关联.
- 为了确定IL-6信号缺陷是否会减轻CHIP患者的AAA风险.
主要方法:
- 使用了英国生物库数据,这些数据来自没有流行的AAA的参与者.
- 评估了CHIP (任何,大,基因特异性) 与事件AAA的关联.
- 检查了IL6R p.Asp358Ala (IL-6缺陷代理) 的保护作用,根据CHIP状态分层分层,并测试了基因环境相互作用.
主要成果:
- CHIP与AAA风险增加有关 (HR 1.21),大型CHIP克隆显示出更强的效果 (HR 1.35).
- 以ASXL1为媒介的CHIP具有最高的效果大小 (HR 2.10).
- 在大型CHIP携带者中,遗传IL-6缺乏减弱了AAA风险 (HR 0.48).
结论:
- CHIP与发展AAA的更高风险有关.
- 在大型CHIP载体中,遗传IL-6缺乏似乎降低了AAA风险.
- CHIP为AAA预防和治疗策略提供了一个潜在的目标.
相关概念视频
01:21Hematopoiesis
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
01:19Multipotency of Hematopoietic Stem Cells
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
01:21Lineage Commitment
Commitment is the process whereby stem cells:
01:30Aneurysm I: Introduction
An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
01:21Aneurysm II: Clinical Manifestations and Diagnostic Studies
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
01:26Aneurysm III: Interprofessional Care
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...